脑部放疗,上午比下午敏感许多!
X" I7 \8 d0 f* Y( X) ~, N" b% J7 R& v- F7 \8 Q) W8 X
" v1 H0 F; `2 Z! Y0 e& f& K5 lCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
7 E" W( S, ]/ N1 F, {% Z: [& K1 ^Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?1 t- W$ c, N4 m7 h
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.# P0 A, g6 Q: k/ e4 z5 D, z3 X
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.8 h0 e7 I/ Q/ i' U5 U# j
6 v$ }) T" e) ^0 q. l. {" \' JAbstract$ M; x1 R ^+ p* v! D- L: Z |7 Q
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.& p# w; ~( g4 u
" m: ^; \6 \* ^8 T `* X# {; `( H
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
1 ~7 R5 U! Y$ g) H3 a- W. G" z1 U, T7 c, X4 E
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)./ ]6 i$ _1 p) g2 Z$ F
! p a1 |) K) @: I0 CCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.: V: U8 m( U4 i- j+ `( W: E) u* g
* t6 Z/ }( [7 |7 ~ |